Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
John C. Byrd(University of Cincinnati), C. D. Bloomfield(Leukemia Research Foundation), Charles A. Schiffer(Veterans Health Administration), Ramana Tantravahi(Temple University), E S Trikha, Maria R. Baer(University of Maryland, Baltimore), Mazin Β. Qumsiyeh(University of Maryland, Baltimore), Shekar Patil, Andrew J. Carroll(University of Alabama at Birmingham), D C Arthur, R. John Mayer, R B Weiss, FR Davey, David Lawrence(VA Connecticut Healthcare System), J O Moore
Cited by 236
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k